{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:18:01Z","timestamp":1779099481374,"version":"3.51.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cerebral embolic protection (CEP) devices have been developed to reduce periprocedural embolization through transcatheter aortic valve replacement (TAVR), yet their clinical benefit remains uncertain. This study aimed to systematically evaluate the efficacy and safety of CEP devices during TAVR using evidence restricted to randomized controlled trials (RCTs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review and meta-analysis following PRISMA guidelines. MEDLINE, Embase, Web of Science, Scopus, and Cochrane CENTRAL were searched through July 2025 for RCTs comparing CEP devices vs. no protection in patients undergoing TAVR. The primary outcome was the all-cause stroke. Random-effects model was applied for the primary analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Nine RCTs comprising 11,696 patients (6,000 patients in CEP, 5,696 patients in control) were analyzed. CEP use did not significantly reduce the overall risk of all-cause stroke\n                      <jats:bold>(<\/jats:bold>\n                      RR 0.92; 95% CI 0.73\u20131.14;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.43\n                      <jats:bold>).<\/jats:bold>\n                      The results were consistent across different subgroups, either Sentinel (filter device)\n                      <jats:bold>(<\/jats:bold>\n                      RR 0.88; 95% CI 0.70\u20131.11; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.00%) or TriGuard (deflection device)\n                      <jats:bold>(<\/jats:bold>\n                      RR 1.40; 95% CI 0.67\u20132.94; I\n                      <jats:sup>2<\/jats:sup>\n                      \u2009=\u20090.00%) (P\n                      <jats:sub>interaction<\/jats:sub>\n                      \u2009=\u20090.50). Similarly, no significant differences between the two groups were observed for the risk of all-cause mortality, disabling stroke, non-disabling stroke, cardiovascular mortality, transient ischemic attack, major adverse cardiovascular and cerebrovascular events, major bleeding, major vascular complications, or acute kidney injury.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among patients undergoing TAVR, CEP devices could not reduce the risk of stroke compared with the control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251114450<\/jats:ext-link>\n                      , CRD420251114450.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1782285","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:33:30Z","timestamp":1779096810000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes after using cerebral embolic protection devices during transcatheter aortic valve replacement: an updated meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Mohamed Saad","family":"Sayed","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Beni-Suef University","place":["Beni Suef, Egypt"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amro K.","family":"AlQurm","sequence":"additional","affiliation":[{"name":"School of Medicine, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed Mohaned","family":"Rasheed","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenda Yousef","family":"Abedal- Kareem","sequence":"additional","affiliation":[{"name":"School of Medicine, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeb M.","family":"Albsoul","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Yarmouk University","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara K.","family":"AlQurm","sequence":"additional","affiliation":[{"name":"School of Medicine, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shatha M.","family":"Ramadneh","sequence":"additional","affiliation":[{"name":"School of Medicine, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude N.","family":"Haddad","sequence":"additional","affiliation":[{"name":"School of Medicine, Jordan University of Science and Technology","place":["Irbid, Jordan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obadah","family":"Aqtash","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Baylor Scott & White, the Heart Hospital","place":["Plano, TX, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tulio","family":"Caldonazo","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Jena University Hospital","place":["Jena, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.athoracsur.2019.01.031","article-title":"Prognosis of severe asymptomatic aortic stenosis with and without surgery","volume":"108","author":"Campo","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"B2","first-page":"844","article-title":"Characterization of the early lesion of \u201cdegenerative\u201d valvular aortic stenosis","volume":"90","author":"Otto","year":"1994","journal-title":"Histol Immunohistochem Stud Circ"},{"key":"B3","first-page":"2021","article-title":"ACC\/AHA guideline for the management of patients with valvular heart disease","volume":"77","author":"Otto","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e002981","DOI":"10.1161\/CIRCINTERVENTIONS.115.002981","article-title":"Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER trial (placement of aortic transcatheter valves)","volume":"9","author":"Kapadia","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"ezaf215","DOI":"10.1093\/ejcts\/ezaf215","article-title":"Surgical versus transcatheter treatment of aortic valve stenosis-a meta-analysis of low-risk randomized trials with completed 5-year follow-up","volume":"67","author":"Doenst","year":"2025","journal-title":"Eur J Cardiothorac Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fcvm.2018.00150","article-title":"The role of cerebral embolic protection devices during transcatheter aortic valve replacement","volume":"5","author":"Demir","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.tcm.2018.01.007","article-title":"Cerebral protection devices during transcatheter aortic valve implantation","volume":"28","author":"Vlastra","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.37616\/2212-5043.1379","article-title":"Saudi Heart association\/national heart center\/Saudi Arabian cardiac interventional society\/Saudi society for cardiac surgeons\/Saudi cardiac imaging group 2023 TAVI guidelines","volume":"36","author":"Albacker","year":"2024","journal-title":"J Saudi Heart Assoc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/14779072.2024.2385989","article-title":"Cerebral embolic protection for stroke prevention during transcatheter aortic valve replacement","volume":"22","author":"Basit","year":"2024","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1056\/NEJMoa2415120","article-title":"Routine cerebral embolic protection during transcatheter aortic-valve implantation","volume":"392","author":"Kharbanda","year":"2025","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"101127","DOI":"10.1016\/j.cpcardiol.2022.101127","article-title":"Cerebral embolic protection during transcatheter aortic valve implantation: updated systematic review and meta-analysis","volume":"48","author":"Zahid","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"B14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan \u2014 a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium-2 consensus document\u2020","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur Heart J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jacc.2016.11.045","article-title":"Proposed standardized neurological endpoints for cardiovascular clinical trials","volume":"69","author":"Lansky","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"key":"B18","year":"2023"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e39471","DOI":"10.1371\/journal.pone.0039471","article-title":"Evolution of heterogeneity (I2) estimates and their 95% confidence intervals in large meta-analyses","volume":"7","author":"Thorlund","year":"2012","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341x.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br Med J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"B23","volume-title":"Stata Statistical Software: Release 17","year":"2021"},{"key":"B24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/jama.2016.10302","article-title":"Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI randomized clinical trial","volume":"316","author":"Haussig","year":"2016","journal-title":"JAMA"},{"key":"B25","first-page":"686","article-title":"Intraaortic protection from embolization in patients undergoing transaortic transcatheter aortic valve implantation","volume-title":"Ann Thorac Surg","author":"Wendt","year":"2015"},{"key":"B26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jcin.2020.11.011","article-title":"Randomized evaluation of TriGuard 3 cerebral embolic protection after transcatheter aortic valve replacement: rEFLECT II","volume":"5","author":"Nazif","year":"2021","journal-title":"J Am Coll Cardiol Intv"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1093\/eurheartj\/ehab213","article-title":"A randomized evaluation of the TriGuardTM HDH cerebral embolic protection device to reduce the impact of cerebral embolic LEsions after TransCatheter aortic valve ImplanTation: the REFLECT I trial","volume":"42","author":"Lansky","year":"2021","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/eurheartj\/ehv191","article-title":"A prospective randomized evaluation of the TriGuardTM HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial","volume":"36","author":"Lansky","year":"2015","journal-title":"Eur Heart J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMoa2204961","article-title":"Embolic protection during transcatheter aortic-valve replacement","volume":"387","author":"Kapadia","year":"2022","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4244\/EIJV12I4A84","article-title":"Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial","volume":"12","author":"Van Mieghem","year":"2016","journal-title":"EuroIntervention"},{"key":"B31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jacc.2016.10.023","article-title":"Protection against cerebral embolism during transcatheter aortic valve replacement","volume":"69","author":"Kapadia","year":"2017","journal-title":"JACC"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e793","DOI":"10.4244\/EIJ-D-23-01087","article-title":"Cerebrovascular events after transcatheter aortic valve implantation","volume":"20","author":"Reddy","year":"2024","journal-title":"EuroIntervention"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.amjcard.2016.08.013","article-title":"Neurologic complications of unprotected transcatheter aortic valve implantation (from the neuro-TAVI trial)","volume":"118","author":"Lansky","year":"2016","journal-title":"Am J Cardiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"100961","DOI":"10.1016\/j.cpcardiol.2021.100961","article-title":"Trends and outcomes of ischemic stroke after transcatheter aortic valve implantation, A US national propensity matched analysis","volume":"47","author":"Zahid","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"107054","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107054","article-title":"Outcomes and predictors of periprocedural stroke after transcatheter aortic valve implantation","volume":"32","author":"Castelo","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101842","DOI":"10.1016\/j.ijcha.2025.101842","article-title":"Effectiveness of cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of randomized trials","volume":"61","author":"Caminiti","year":"2025","journal-title":"IJC Heart Vasc"},{"key":"B37","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.carrev.2019.11.014","article-title":"Real-World experience of the sentinel cerebral protection device: insights from the FDA manufacturer and user facility device experience (MAUDE) database","volume":"21","author":"Case","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.31083\/j.rcm2501003","article-title":"Patient characteristics and outcomes associated with sentinel protection device use in patients with aortic valve disease undergoing TAVR in a \u201creal-world\u201d setting","volume":"25","author":"Jabagi","year":"2024","journal-title":"Rev Cardiovasc Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1782285\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T09:33:37Z","timestamp":1779096817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1782285\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":38,"alternative-id":["10.3389\/fcvm.2026.1782285"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1782285","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"article-number":"1782285"}}